Controversy has surrounded several recent papers from Dr. Friedhelm Herrmann's laboratories in Berlin and Ulm, Germany. Following the discovery that some of the data in a paper appearing in 1996 in theJournal of Experimental Medicine were fabricated, suspicion over other papers from this group was raised. Subsequently, some, but not all, coauthors on many of the group's papers, including several published in BLOOD, have requested that their names be removed from the work(s). The authors' requests and our own review of the German Joint Commission's report on the matter have led the Editor to conclude that data was indeed falsified. As a result, the BLOODJournal regrets to inform its readers that the following publications have been retracted:
Skip Nav Destination
RETRACTION|
May 15, 1999
Correction for vol. 78, p. 2070
Blood (1999) 93 (10): 3573.
Connected Content
This is a retraction to:
Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor
This is a retraction to:
Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells
This is a retraction to:
Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor
This is a retraction to:
Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein
This is a retraction to:
Interleukin-3 and granulocyte-macrophage colony-stimulating factor induce activation of the MAPKAP kinase 2 resulting in in vitro serine phosphorylation of the small heat shock protein (Hsp 27)
This is a retraction to:
Transforming growth factor-beta relieves stem cell factor-induced proliferation of myelogenous leukemia cells through inhibition of binding of the transcription factor NF-jun
This is a retraction to:
Interleukin-1 beta (IL-1 beta) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony- stimulating factor (GM-CSF), M-CSF, and IL-3
This is a retraction to:
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
Citation
Correction for vol. 78, p. 2070. Blood 1999; 93 (10): 3573. doi: https://doi.org/10.1182/blood.V93.10.3573
Download citation file:
May 15 1999
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal